Tumor blood vessel visualization

International Journal of Developmental Biology

Volumn 55, Issue 4-5, 2011, Pages 535-546

  Missbach Guentner, Jeannine ^a   Hunia, Julia ^b   Alves, Frauke ^b,c  

^a Department of Diagnostic Radiology ^*  (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Angiogenesis inhibitor; Animal models; Antiangiogenic therapy; Noninvasive imaging technique; Tumor monitoring

Indexed keywords

BEVACIZUMAB; PAZOPANIB; VADIMEZAN;

ARTICLE; BIOLUMINESCENCE IMAGING; BONE METASTASIS; COLON TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DOPPLER ECHOGRAPHY; DRUG RESPONSE; GLIOBLASTOMA; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; IMAGING; MICROSCOPY; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; DIAGNOSTIC IMAGING; FLUORESCENCE; HUMANS; LUMINESCENCE; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MICROSCOPY; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; X-RAY MICROTOMOGRAPHY;

ANIMALIA;

EID: 79960980011     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103229jm     Document Type: Article

References (113)

1. ALCÁZAR J.L. (2006) Tumor angiogenesis assessed by three-dimensional power Doppler ultrasound in early, advanced and metastatic ovarian cancer: A preliminary study. Ultrasound Obstet. Gynecol. 28: 325-329.
2. ALMUTAIRI A., ROSSIN R., SHOKEEN M., HAGOOLY A., ANANTH A., CAPOCCIA B., GUILLAUDEU S., ABENDSCHEIN D., ANDERSON C.J., WELCH M.J., FRÉCHET J.M. (2009) Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc. Natl. Acad. Sci. USA 106: 685-690.
3. ALVES F., DULLIN C., NAPP J., MISSBACH-GUENTNER J., JANNASCH K., MATHEJCZYK J., PARDO L.A., STÜHMER W., TIETZE L.F. (2009) Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice. Eur. J. Radiol. 70: 286-293.
4. BACKER M.V., LEVASHOVA Z., PATEL V., JEHNING B.T., CLAFFEY K., BLANKENBERG F.G., BACKER J.M. (2007) Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat. Med. 13: 504-509.
5. BÄUERLE T., HILBIG H., BARTLING S., KIESSLING F., KERSTEN A., SCHMITT-GRÄFF A., KAUCZOR H.U., DELORME S., BERGER M.R. (2008) Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI. Neoplasia 10: 511-520.
6. BEER A.J., GROSU A.L., CARLSEN J., KOLK A., SARBIA M., STANGIER I., WATZLOWIK P., WESTER H.J., HAUBNER R., SCHWAIGER M. (2007) (18F)galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clin. Cancer Res. 13: 6610-6616.
7. BERGERS G., HANAHAN D., COUSSENS L.M. (1998) Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int. J. Dev. Biol. 42: 995-1002.
8. BLANKENBERG F.G., LEVASHOVA Z., SARKAR S.K., PIZZONIA J., BACKER M.V., BACKER J.M. (2010) Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study. Transl. Oncol. 3: 56-64.
9. BURGESS R.E., YU Y., CHRISTOFORIDIS G.A., BOUREKAS E.C., CHAKERES D.W., SPIGOS D., KANGARLU A., ABDULJALIL A.M., ROBITAILLE P.M. (1999) Human leptomeningeal and cortical vascular anatomy of the cerebral cortex at 8 Tesla. J. Comput. Assist. Tomogr. 23: 850-856.
10. CAI W AND CHEN X. (2007) Nanoplatforms for targeted molecular imaging in living subjects. Small 3: 1840-1854.
11. CAI W., GUZMAN R., HSU A.R., WANG H., CHEN K., SUN G., GERA A., CHOI R., BLISS T., HE L., LI Z.B., MAAG A.L., HORI N., ZHAO H., MOSELEY M., STEINBERG G.K., CHEN X. (2009) Positron emission tomography imaging of poststroke angiogenesis. Stroke 40: 270-277.
12. CAO Y.A., WAGERS A.J., BEILHACK A., DUSICH J., BACHMANN M.H., NEGRIN R.S., WEISSMAN I.L., CONTAG C.H. (2004) Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl. Acad. Sci. USA 101: 221-226.
13. CATANA C., WU Y., JUDENHOFER M.S., QI J., PICHLER B.J., CHERRY S.R. (2006) Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. J. Nucl. Med. 47: 1968-1976.
14. CEELEN W., SMEETS P., BACKES W., VAN DAMME N., BOTERBERG T., DEMETTER P., BOUCKENOOGHE I., DE VISSCHERE M., PEETERS M., PATTYN P. (2006) Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model. Int. J. Radiat. Oncol. Biol. Phys. 64: 1188-1196.
15. CHEN K., CAI W., LI Z.B., WANG H., CHEN X. (2009) Quantitative PET imaging of VEGF receptor expression. Mol. Imaging Biol. 11: 15-22.
16. CHEN X., HOU Y., TOHME M., PARK R., KHANKALDYYAN V., GONZALES-GOMEZ I., BADING J.R., LAUG W.E., CONTI P.S. (2004) Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J. Nucl. Med. 45: 1776-1783.
17. CHEN X. (2006) Multimodality imaging of tumor integrin alphavbeta3 expression. Mini Rev. Med. Chem. 6: 227-234.
18. CHUNG S., SUDO R., VICKERMAN V., ZERVANTONAKIS I.K., KAMM R.D. (2010) Microfluidic platforms for studies of angiogenesis, cell migration, and cell-cell interactions. Sixth International Bio-Fluid Mechanics Symposium and Workshop March 28-30, 2008 Pasadena, California. Ann. Biomed. Eng. 38: 1164-1177.
19. CHRISTOFORIDIS G.A., YANG M., KONTZIALIS M.S., LARSON D.G., ABDULJALIL A., BASSO M., YANG W., RAY-CHAUDHURY A., HEVERHAGEN J., KNOPP M.V., BARTH R.F. (2009) High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide. Invest. Radiol. 44: 375-383.
20. DASHNER R.A., KANGARLU A., CLARK D.L., RAYCHAUDHURY A., CHAKERES D.W. (2004) Limits of 8-Tesla magnetic resonance imaging spatial resolution of the deoxygenated cerebral microvasculature. J. Magn. Reson. Imaging 19: 303-307.
21. DULLIN C., ZIENTKOWSKA M., NAPP J., MISSBACH-GUENTNER J., KRELL H.W., MÜLLER F., GRABBE E., TIETZE L.F., ALVES F. (2009) Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography. Mol. Imaging 8: 2-14.
22. ECCLES S.A. (2004) Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention. Int. J. Dev. Biol. 48: 583-598.
23. EREMINA V., JEFFERSON J.A., KOWALEWSKA J., HOCHSTER H., HAAS M., WEISSTUCH J., RICHARDSON C., KOPP J.B., KABIR M.G., BACKX P.H. et al (2008) VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358: 1129-1136.
24. FOLKMAN J. (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol. 3: 65-71.
25. FORD N.L. AND THORNTON M.M., HOLDSWORTH D.W. (2003) Fundamental image quality limits for microcomputed tomography in small animals. Med. Phys. 30: 2869-2877.
26. FRANC B.L., ACTON P.D., MARI C., HASEGAWA B.H. (2008) Small-animal SPECT and SPECT/CT: important tools for preclinical investigation. J. Nucl. Med. 49: 1651-1663.
27. GAMBHIR S.S. (2002) Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer 2: 683-693.
28. GILES F.J., BELLAMY W.T., ESTROV Z., O'Brien S.M., VERSTOVSEK S., RAVANDI F., BERAN M., BYCOTT P., PITHAVALA Y., STEINFELDT H., et al (2006) The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Leuk. Res. 30: 801-811.
29. GOORDEN M.C. AND BEEKMAN F.J. (2010) High-resolution tomography of positron emitters with clustered pinhole SPECT. Phys. Med. Biol. 55: 1265-1277.
30. GRABHERR S., HESS A., KAROLCZAK M., THALI M.J., FRIESS S.D., KALENDER W.A., DIRNHOFER R., DJONOV V. (2008) Angiofil-mediated visualization of the vascular system by microcomputed tomography: a feasibility study. Microsc. Res. Tech. 71: 551-556.
31. GRESCHUS S., KIESSLING F., LICHY M.P., MOLL J., MUELLER M.M., SAVAI R., ROSE F., RUPPERT C., GÜNTHER A., LUECKE M., FUSENIG N.E., SEMMLER W., TRAUPE H. (2005) Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging. Neoplasia 7: 730-740.
32. GRIFFIOEN A.W., VAN DER SCHAFT D.W., BARENDSZ-JANSON A.F., COX A., STRUIJKER BOUDIER H.A., HILLEN H.F., MAYO K.H. (2001) Anginex, a designed peptide that inhibits angiogenesis. Biochem J. 354: 233-242.
33. HARTNETT L., GLYNN C., NOLAN C.M., GREALY M., BYRNES L. (2010) Insulin-like growth factor-2 regulates early neural and cardiovascular system development in zebrafish embryos. Int. J. Dev. Biol. 54: 573-583.
34. HOFFMAN R.M. (2009) Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins. Clin. Exp. Metastasis 26: 345-355.
35. HSU A.R., HOU L.C., VEERAVAGU A., GREVE J.M., VOGEL H., TSE V., CHEN X. (2006) In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model. Mol. Imaging Biol 8: 315-323.
36. IDÉE J.M., PORT M., ROBERT P., RAYNAL I., PRIGENT P., DENCAUSSE A., LE GRENEUR S., TICHKOWSKY I., LE LEM G., BOURRINET P. et al (2001) Preclinical profile of the monodisperse iodinated macromolecular blood pool agent P743. Invest. Radiol. 36: 41-49.
37. IZZEDINE H., RIXE O., BILLEMONT B., BAUMELOU A., DERAY G. (2007) Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension. Am. J. Kidney. Dis. 50: 203-218.
38. JAIN R.K. (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat. Med. 7: 987-989.
39. JANNASCH K., DULLIN C., HEINLEIN C., KREPULAT F., WEGWITZ F., DEPPERT W., ALVES F. (2009) Detection of different tumor growth kinetics in single transgenic mice with oncogene-induced mammary carcinomas by flat-panel volume computed tomography. Int. J. Cancer 125: 62-70.
40. JENKINS D.E., OEI Y., HORNIG Y.S., YU S.F., DUSICH J., PURCHIO T., CONTAG P.R. (2003) Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin. Exp. Metastasis 20: 733-744.
41. JONES T. (1996) The role of positron emission tomography within the spectrum of medical imaging. Eur. J. Nucl. Med. 23: 207-211.
42. SPANOUDAKI V.C. AND ZIEGLER S.I. (2008) PET & SPECT instrumentation. Handb. Exp. Pharmacol. 185: 53-74.
43. KALENDER W.A. (2003) The use of flat-panel detectors for CT imaging. Radiologe 43: 379-387.
44. KALENDER W.A. AND KYRIAKOU Y. (2007) Flat-detector computed tomography (FD-CT). Eur. Radiol. 17: 2767-2779.
45. KAO C.Y., HOFFMAN E.A., BECK K.C., BELLAMKONDA R.V., ANNAPRAGADA A.V. (2003) Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging. Acad. Radiol. 10: 475-483.
46. KIENAST Y., VON BAUMGARTEN L., FUHRMANN M., KLINKERT W.E., GOLDBRUNNER R., HERMS J., WINKLER F. (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 16: 116-122.
47. KIESSLING F., GRESCHUS S., LICHY M.P., BOCK M., FINK C., VOSSELER S., MOLL J., MUELLER M.M., FUSENIG N.E., TRAUPE H., SEMMLER W. (2004) Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. Nat. Med. 10: 1133-1138.
48. KIESSLING F., HUPPERT J., PALMOWSKI M. (2009) Functional and molecular ultrasound imaging: Concepts and contrast agents. Curr. Med. Chem. 16: 627-642.
49. KIM K.J., LI B. WINER J, ARMANINI M., GILLETT N., PHILLIPS H.S., FERRARA N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844.
50. KISELEV V.G., STRECKER R., ZIYEH S., SPECK O., HENNIG J. (2005) Vessel size imaging in humans. Magn. Reson. Med. 53: 553-563.
51. KLIBANOV A.L. (2006) Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest. Radiol. 41: 354- 362.
52. KOBAYASHI H., REIJNDERS K., ENGLISH S., YORDANOV A.T., MILENIC D.E., SOWERS A.L., CITRIN D., KRISHNA M.C., WALDMANN T.A., MITCHELL J.B., BRECHBIEL M.W. (2004) Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation. Clin. Cancer Res. 10: 7712-7720.
53. KOBAYASHI N., ALLEN N., CLENDENON N.R., KO L.W. (1980) An improved rat brain-tumor model. J. Neurosurg. 53: 808-815.
54. KOEHL G.E., GAUMANN A., GEISSLER E.K. (2009) Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies. Clin Exp Metastasis 26: 329-344.
55. KOSSODO S., PICKARSKI M., LIN S.A., GLEASON A., GASPAR R., BUONO C., HO G., BLUSZTAJN A., CUNEO G., ZHANG J. et al (2009) Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT). Mol. Imaging Biol. 12: 488-499.
56. LEVASHOVA Z., BACKER M., BACKER J.M., BLANKENBERG F.G. (2008) Direct site-specific labeling of the Cys-tag moiety in scVEGF with technetium 99m. Bioconjug. Chem. 19: 1049-1054.
57. LI Y., GONZALEZ S., TERWEY T.H., WOLCHOK J., LI Y., ARANDA I., TOLEDO-CROW R., HALPERN A.C. (2009) Dual mode reflectance and fluorescence confocal laser scanning microscopy for in vivo imaging melanoma progression in murine skin. J. Invest. Dermatol. 125: 798-804.
58. LIJOWSKI M., CARUTHERS S., HU G., ZHANG H., SCOTT M.J., WILLIAMS T., ERPELDING T., SCHMIEDER A.H., KIEFER G., GULYAS G., ATHEY P.S., GAFFNEY P.J., WICKLINE S.A., LANZA G.M. (2009) High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model. Invest. Radiol. 44: 15-22.
59. LIN K.Y., MARICEVICH M., BARDEESY N., WEISSLEDER R., MAHMOOD U. (2008) In vivo quantitative microvasculature phenotype imaging of healthy and malignant tissues using a fiber-optic confocal laser microprobe. Transl. Oncol. 1: 84-94.
60. LINDNER J.R. (2004) Molecular imaging with contrast ultrasound and targeted microbubbles. J. Nucl. Cardiol. 11: 215-221.
61. MASSOUD T.F., GAMBHIR S.S. (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17: 545-580.
62. MATSUMOTO S., YASUI H., BATRA S., KINOSHITA Y., BERNARDO M., MUNASINGHE J.P., UTSUMI H., CHOUDHURI R., DEVASAHAYAM N., SUBRAMANIAN S., MITCHELL J.B., KRISHNA M.C. (2009) Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI. Proc. Natl. Acad. Sci. USA 106: 17898-17903.
63. MCELROY W.D. (1951) Properties of the reaction utilizing adenosinetriphosphate for bioluminescence. J. Biol. Chem. 191: 547-557.
64. MCINTYRE J.O., MATRISIAN L.M. (2003) Molecular imaging of proteolytic activity in cancer. J. Cell Biochem. 90: 1087-1097.
65. MISSBACH-GUENTNER J., DULLIN C., ZIENTKOWSKA M., DOMEYER-MISSBACH M., KIMMINA S., OBENAUER S., KAUER F., STÜHMER W., GRABBE E., VOGEL W.F., ALVES F. (2007) Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model. Neoplasia 9: 755-765.
66. MISSBACH-GUENTNER J., DULLIN C., KIMMINA S., ZIENTKOWSKA M., DOMEYER-MISSBACH M., MALZ C., GRABBE E., STÜHMER W., ALVES F. (2008) Morphologic changes of mammary carcinomas in mice over time as monitored by flat-panel detector volume computed tomography. Neoplasia 10: 663-673.
67. MONTET X., FIGUEIREDO J.L., ALENCAR H., NTZIACHRISTOS V., MAHMOOD U., WEISSLEDER R. (2007) Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology 242: 751-758.
68. MOROZ E., CARLIN S., DYOMINA K., BURKE S., THALER H.T., BLASBERG R., SERGANOVA I. (2009) Real-time imaging of HIF-1alpha stabilization and degradation. PLoS One 4: e5077.
69. MULDER W.J., VAN DER SCHAFT D.W., HAUTVAST P.A., STRIJKERS G.J., KONING G.A., STORM G., MAYO K.H., GRIFFIOEN A.W., NICOLAY K. (2007) Early in vivo assessment of angiostatic therapy efficacy by molecular MRI. FASEB J. 21: 378-383.
70. NGUYEN HUU S., OSTER M., UZAN S., CHAREYRE F., ARACTINGI S., KHOSROTEHRANI K. (2007) Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. Proc. Natl. Acad. Sci. USA 104: 1871-1876.
71. NILSSON F., KOSMEHL H., ZARDI L., NERI D. (2001) Targeted delivery of tissuefactor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice. Cancer Res. 61: 711-716.
72. NTZIACHRISTOS V., TUNG C.H., BREMER C., WEISSLEDER R. (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat. Med. 8: 757-760.
73. O'REILLY M.S., BOEHM T., SHING Y., FUKAI N., VASIOS G., LANE W.S., FLYNN E., BIRKHEAD J.R., OLSEN B.R., FOLKMAN J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285.
74. PADHANI A.R. AND NEEMAN M. (2001) Challenges for imaging angiogenesis. Br. J. Radiol. 74: 886-890.
75. PALMOWSKI M., HUPPERT J., HAUFF P., REINHARDT M., SCHREINER K., SOCHER M.A., HALLSCHEIDT P., KAUFFMANN G.W., SEMMLER W., KIESSLING F. (2008) Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment. Cancer Res. 68: 7042-7049.
76. PALMOWSKI M., PESCHKE P., HUPPERT J., HAUFF P., REINHARDT M., MAURER M., KARGER C.P., SCHOLZ M., SEMMLER W., HUBER P.E., KIESSLING F.M. (2009) Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions. Neoplasia 11: 856-863.
77. PERSIGEHL T., BIEKER R., MATUSZEWSKI L., WALL A., KESSLER T., KOOIJMAN H., MEIER N., EBERT W., BERDEL W.E., HEINDEL W., MESTERS R.M., BREMER C. (2007) Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice. Radiology 244: 449-456.
78. PHELPS M.E. (2000) PET: the merging of biology and imaging into molecular imaging. J. Nucl. Med. 41: 661-681.
79. PILLAI R., MARINELLI E.R., FAN H., NANJAPPAN P., SONG B., VON WRONSKI M.A., CHERKAOUI S., TARDY I., POCHON S., SCHNEIDER M., NUNN A.D., SWENSON R.E. (2010) A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis. Bioconjug. Chem. 21: 556-562.
80. PIYAWATTANAMETHA W., COCKER E.D., BURNS L.D., BARRETTO R.P., JUNG J.C., RA H., SOLGAARD O., SCHNITZER M.J. (2009) In vivo brain imaging using a portable 2.9 g two-photon microscope based on a microelectromechanical systems scanning mirror. Opt. Lett. 34: 2309-2311.
81. PUDLISZEWSKI M. AND PARDANAUD L. (2005) Vasculogenesis and angiogenesis in the mouse embryo studied using quail/mouse chimeras. Int. J. Dev. Biol. 49: 355-361.
82. REHEMTULLA A., STEGMAN L.D., CARDOZO S.J., GUPTA S., HALL D.E., CONTAG C.H., ROSS B.D. (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2: 491-495.
83. RIBATTI D., VACCA A., RONCALI L., DAMMACCO F. (1996) The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int. J. Dev. Biol. 40: 1189-1197.
84. RUOSLAHTI E. (2002) Specialization of tumour vasculature. Nat. Rev. Cancer 2: 83-90.
85. SAVAI R., LANGHEINRICH A.C., SCHERMULY R.T., PULLAMSETTI S.S., DUMITRASCU R., TRAUPE H., RAU W.S., SEEGER W., GRIMMINGER F., BANAT G.A. (2009) Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer. Neoplasia 11: 48-56.
86. SCHMIEDER A.H., CARUTHERS S.D., ZHANG H., WILLIAMS T.A., ROBERTSON J.D., WICKLINE S.A., LANZA G.M. (2008) Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model. FASEB J. 22: 4179-4189.
87. SEDELAAR J.P., VAN LEENDERS G.J., HULSBERGEN-VAN DE KAA C.A., VAN DER POEL H.G., VAN DER LAAK J.A., DEBRUYNE F.M., WIJKSTRA H., DE LA ROSETTE J.J. (2001) Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur. Urol. 40: 285-293.
88. SESHADRI M. AND CIESIELSKI M.J. (2009) MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas. J. Cereb. Blood Flow Metab. 29: 1373-1382.
89. SEVICK-MURACA E.M., HOUSTON J.P., GURFINKEL M. (2002) Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr. Opin. Chem. Biol. 6:642-650.
90. SHOKEEN M. AND ANDERSON C.J. (2009) Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). Acc. Chem. Res. 42: 832-841.
91. SMITH L.A., TIFFIN N., THOMSON M., CROSS S.S., HURLSTONE D.P. (2008) Chromoscopic endomicroscopy: in vivo cellular resolution imaging of the colorectum. J. Gastroenterol. Hepatol. 23: 1009-1023.
92. MAEHARA N. (2008) Experimental microcomputed tomography study of the 3D microangioarchitecture of tumors. Eur. Radiol. 13: 1559-1565.
93. STONE R.L., SOOD A.K., COLEMAN R.L. (2010) Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer. Lancet Oncol. 11: 465-475.
94. TOMBACH B., REIMER P., BREMER C., ALLKEMPER T., ENGELHARDT M., MAHLER M., EBERT W., HEINDEL W. (2004) First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study. NMR Biomed. 17: 500-506.
95. TOWNSEND D.W. AND BEYER T. (2002) A combined PET/CT scanner: the path to true image fusion. Br. J. Radiol. 75: 24-30.
96. TOZER G.M., KANTHOU C., BAGULEY B.C. (2005) Disrupting tumour blood vessels. Nat. Rev. Cancer 5: 423-435.
97. TROPRÈS I., LAMALLE L., PÉOC'H M., FARION R., USSON Y., DÉCORPS M., RÉMY C. (2004) In vivo assessment of tumoral angiogenesis. Magn. Reson. Med. 51: 533-541.
98. TSENG J., DUNNWALD L.K., SCHUBERT E.K., LINK J.M., MINOSHIMA S., MUZI M., MANKOFF D.A. (2004) 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. J. Nucl. Med. 45: 1829-1837.
99. TSIEN R.Y. (2005) Building and breeding molecules to spy on cells and tumors. FEBS Lett. 579: 927-932.
100. VAUPEL P., KALLINOWSKI F., OKUNIEFF P. (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49: 6449-6465.
101. WAHL R.L., HUTCHINS G.D., BUCHSBAUM D.J., LIEBERT M., GROSSMAN H.B., FISHER S. (1991) 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer 67: 1544-1550.
102. WANG X., PANG Y., KU G., XIE X., STOICA G., WANG L.V. (2003) Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain. Nat. Biotechnol. 21: 803-806.
103. WEICHERT J.P., LEE F.T., CHOSY S.G., LONGINO M.A., KUHLMAN J.E., HEISEY D.M., LEVERSON G.E. (2000) Combined hepatocyte-selective and blood-pool contrast agents for the CT detection of experimental liver tumors in rabbits. Radiology 216: 856-871.
104. WEISSLEDER R., ELIZONDO G., WITTENBERG J., RABITO C.A., BENGELE H.H., JOSEPHSON L. (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175: 489-493.
105. WEISSLEDER R., TUNG C.H., MAHMOOD U., BOGDANOV A. JR. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17: 375-378.
106. WEISSLEDER R. AND PITTET M.J. (2008) Imaging in the era of molecular oncology. Nature 452: 580-589.
107. WILSON C.B., LAMMERTSMA A.A., MCKENZIE C.G., SIKORA K., JONES T. (1992) Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. Cancer Res. 52: 1592-1597.
108. WINKLER F., KIENAST Y., FUHRMANN M., VON BAUMGARTEN L., BURGOLD S., MITTEREGGER G., KRETZSCHMAR H., HERMS J. (2009) Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis. Glia 57: 1306-1315.
109. YANG M., LI L., JIANG P., MOOSSA A.R., PENMAN S., HOFFMAN R.M. (2003) Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc. Natl. Acad. Sci. USA 100: 14259-14262.
110. YANG W.T., TSE G.M., LAM P.K., METREWELI C., CHANG J. (2002) Correlation between color power Doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. J. Ultrasound Med. 21: 1227-1235.
111. ZAKARIJA A. AND SOFF G. (2005) Update on angiogenesis inhibitors. Curr. Opin. Oncol. 17: 578-583.
112. ZETTER B.R. (1998) Angiogenesis and tumor metastasis. Annu Rev. Med. 49: 407-424.
113. ZHANG C., JUGOLD M., WOENNE E.C., LAMMERS T., MORGENSTERN B., MUELLER M.M., ZENTGRAF H., BOCK M., EISENHUT M., SEMMLER W., KIESSLING F. (2007) Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 67: 1555-1562.